Endotoxin-induced myocardial dysfunction: Evidence for a role of sphingosine production

Critical Care Medicine

Volumn 32, Issue 2, 2004, Pages 495-501

  Favory, Raphael ^a,b   Lancel, Steve ^c   Marchetti, Philippe ^c   Mordon, Serge ^a   Chopin, Claude ^a   Formstecher, Pierre ^c   Neviere, Remi ^a,b  

^a France Institut Pasteur de Lille   (France)

^b UNIV LILLE   (France)

^c INSERM   (France)

Author keywords

Cardiomyocyte; Endotoxin; Heart failure; Mitochondria; Shock; Sphingosine

Indexed keywords

ENDOTOXIN; ENZYME INHIBITOR; ETHANOLAMINE DERIVATIVE; N OLEOYLETHANOLAMINE; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CALCIUM TRANSPORT; CARDIOVASCULAR FUNCTION; CELL FRACTIONATION; CELL MEMBRANE POTENTIAL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; FLUORESCENCE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CELL; HEART MUSCLE PERFUSION; MALE; MEAN ARTERIAL PRESSURE; MITOCHONDRIAL MEMBRANE; MYOCARDIAL DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTIC SHOCK; SIGNAL TRANSDUCTION;

EID: 1242342720     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000109452.36271.FA     Document Type: Article

References (38)

1. Parrillo JE, Parker MM, Natanson C, et al: Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990; 113:227-242
2. Suffredini AF, Fromm RE, Parker MM, et al: The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989; 321:280-287
3. Natanson C, Eichenholz PW, Danner RL, et al: Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 1989; 169:823-832
4. Grocott-Mason RM, Shah AM: Cardiac dysfunction in sepsis: New theories and clinical implications. Intensive Care Med 1998; 24:286-295
5. Bone RC: The pathogenesis of sepsis. Ann Intern Med 1991; 115:457-469
6. Kumar A, Thota V, Dee L, et al: Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 1996; 183:949-958
7. Cain BS, Meldrum DR, Dinarello CA, et al: Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function. Crit Care Med 1999; 27:1309-1318
8. Edmunds NJ, Woodward B: Effects of tumour necrosis factor-alpha on the coronary circulation of the rat isolated perfused heart: A potential role for thromboxane A2 and sphingosine. Br J Pharmacol 1998; 124:493-498
9. Edmunds NJ, Lal H, Woodward B: Effects of tumour necrosis factor-alpha on left ventricular function in the rat isolated perfused heart: Possible mechanisms for a decline in cardiac function. Br J Pharmacol 1999; 126:189-196
10. Muller-Werdan U, Schumann H, Fuchs R, et al: Tumor necrosis factor alpha (TNF alpha) is cardiodepressant in pathophysiologically relevant concentrations without inducing inducible nitric oxide-(NO)-synthase (iNOS) or triggering serious cytotoxicity. J Mol Cell Cardiol 1997; 29:2915-2923
11. Kumar A, Brar R, Wang P, et al: Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. Am J Physiol 1999; 276:R265-R276
12. Finkel MS, Oddis CV, Jacob TD, et al: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992; 257:387-389
13. Stein B, Frank P, Schmitz W, et al: Endotoxin and cytokines induce direct cardiodepressive effects in mammalian cardiomyocytes via induction of nitric oxide synthase. J Mol Cell Cardiol 1996; 28:1631-1639
14. Yokoyama T, Vaca L, Rossen RD, et al: Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 1993; 92:2303-2312
15. Sugishita K, Kinugawa K, Shimizu T, et al: Cellular basis for the acute inhibitory effects of IL-6 and TNF-alpha on excitation-contraction coupling. J Mol Cell Cardiol 1999; 31:1457-1467
16. Joe EK, Schussheim AE, Longrois D, et al: Regulation of cardiac myocyte contractile function by inducible nitric oxide synthase (iNOS): Mechanisms of contractile depression by nitric oxide. J Mol Cell Cardiol 1998; 30:303-315
17. Tatsumi T, Matoba S, Kawahara A, et al: Cytokine-induced nitric oxide production inhibits mitochondrial energy production and impairs contractile function in rat cardiac myocytes. J Am Coll Cardiol 2000; 35:1338-1346
18. Kelly RA, Balligand JL, Smith TW: Nitric oxide and cardiac function. Circ Res 1996; 79:363-380
19. Oral H, Dorn GW, Mann DL: Sphingosine mediates the immediate negative inotropic effects of TNF in the adult mammalian cardiomyocytes. J Biol Chem 1997; 272:4836-4842
20. Webster RJ, Sabbadini RA, Dettbarn CA, et al: Sphingosine effects on the contractile behavior of skinned cardiac myocytes. J Mol Cell Cardiol 1994; 26:1273-1290
21. Friedrichs GS, Swillo RE, Jow B, et al: Sphingosine modulates myocyte electrophysiology, induces negative inotropy, and decreases survival after myocardial ischemia. J Cardiovasc Pharmacol 2002; 39:18-28
22. Grandel U, Fink L, Blum A, et al: Endotoxin-induced myocardial tumor necrosis factor-alpha synthesis depresses contractility of isolated rat hearts: Evidence for a role of sphingosine and cyclooxygenase-2-derived thromboxane production. Circulation 2000; 102:2758-2764
23. Delogu G, Famularo G, Amati F, et al: Ceramide concentrations in septic patients: A possible marker of multiple organ dysfunction syndrome. Crit Care Med 1999; 27:2413-2417
24. Neviere R, Fauvel H, Chopin C, et al: Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis. Am J Respir Crit Care Med 2000; 163:218-225
25. Scaduto RC, Grotyohann LW: Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys J 1998; 1999:469-477
26. Buckman JF, Reynolds IJ: Spontaneous changes in mitochondrial membrane potential in cultured neurons. J Neurosci 2001; 21:5054-5065
27. Thielmann M, Dorge H, Martin C, et al: Myocardial dysfunction with coronary microembolization: Signal transduction through a sequence of nitric oxide, tumor necrosis factor-alpha, and sphingosine. Circ Res 2002; 90:807-813
28. Stamm C, Cowan DB, Friehs I, et al: Rapid endotoxin-induced alterations in myocardial calcium handling: Obligatory role of cardiac TNF-alpha. Anesthesiology 2001; 95:1396-1405
29. Kolesnick R: The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J Clin Invest 2002; 110:3-8
30. Lecour S, Smith RM, Woodward B, et al: Identification of a novel role for sphingolipid signaling in TNF-α and ischemic preconditioning mediated cardioprotection. J Mol Cell Cardiol 2002; 34:509-518
31. Granton JT, Goddard CM, Allard MF, et al: Leukocytes and decreased left-ventricular contractility during endotoxemia in rabbits. Am J Respir Crit Care Med 1997; 155:1977-1983
32. Epps DE, Cardin AD: The interaction of N-oleoylethanolamine with phospholipid bilayers. Biochim Biophys Acta 1987; 903:533-541
33. Amadou A, Nawrocki A, Best-Belpomme M, et al: Arachidonic acid mediates dual effect of TNF-alpha on Ca2+ transients and contraction of adult rat cardiomyocytes. Am J Physiol Cell Physiol 2002; 282:C1339-C1347
34. McDonough PM, Yasui K, Betto R, et al: Control of cardiac Ca2+ levels. Inhibitory actions of sphingosine on Ca2+ transients and L-type Ca2+ channel conductance. Circ Res 1994; 75:981-985
35. Bozkurt B, Kribbs SB, Clubb FJ Jr, et al: Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998; 97:1382-1391
36. Garcia-Ruiz C, Colell A, Mari M, et al: Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J Biol Chem 1997; 272:11369-11377
37. Halestrap AP, Kerr PM, Javadov S, et al: Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. Biochim Biophys Acta 1998; 1366:79-94
38. Drobnik W, Liebisch G, Audebert FX, et al: Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients. J Lipid Res 2003; 44:754-761